LMHRA Embarks on Validation of Key Regulatory Documents
-To Strengthen Quality Management System
The Liberia Medicines and Health Products Regulatory Authority (LMHRA) has taken a significant step towards enhancing its regulatory framework by initiating the validation of 40 key regulatory documents.
The exercise, which commenced on June 3, 2025, under the leadership of Dr. Luke L. Bawo, aims to reinforce the institution's commitment to international certification and recognition.
LMHRA, as a regulatory agency is striving to achieve several international standards, including the ISO 17025 accreditation for its Quality Control Laboratory, attaining World Health Organization (WHO) Maturity Level Three, and renewing its ISO 9001:2015 certification by 2026.
These milestones, are said to be underscored by LMHRA’s dedication to maintaining the highest standards in ensuring safety, efficacy, and quality of medicines and health products in Liberia.
Speaking during the opening, the Deputy Managing Director of LMHRA, Dr. Patricia Quaye Freeman stressed the importance of the exercise.
According to her, the documents when validated, will serve as a working guide for the institution.
“By engaging key stakeholders in the validation process, LMHRA is reinforcing its commitment to transparency, accountability, and excellence. As the agency continues to pursue these high-level certifications, its efforts signal a stronger and more effective regulatory environment that prioritizes public health and consumer safety in Liberia,” Dr. Quaye-Freeman added.
For his part, the Manager of Quality Management System, Dr. Thomas B. L. Kokulo emphasized that the practice is in line with best international standards, and timely benefits for the public through improved healthcare products and services in Liberia.
The validation process, he said, will cover 17 regulations, 19 guidelines, and four manuals critical instruments that guide LMHRA’s operational framework.
Adding that the documents are indispensable to the agency’s ability to function effectively, as they provide the necessary legal and procedural foundation for ensuring regulatory compliance.
"The completion and implementation of these documents will significantly boost efficiency and productivity within LMHRA, helping the entity to meet its mandate of ensuring the safety and quality of health products in Liberia," stated Dr. Kokulo.
The validation exercise which is currently ongoing at the LMHRA’s head office, is expected to last for four days, bringing together stakeholders and selected agency staffers to review and finalize the documents.
'Their expertise and recommendations, according to report will ensure that LMHRA operates within internationally recognized best practices, ultimately benefiting the public through improved healthcare products and services'.
'As LMHRA advances toward these ambitious goals, it’s paving the way for a more robust regulatory system in the country', the report added.